What is the management approach for a 25-year-old female with generalized upper gastrointestinal (GI) discomfort, presenting with hyperglycemia (>2000 mg/dL), ketonuria, hematuria, and proteinuria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diabetic Ketoacidosis (DKA) with Hematuria and Proteinuria

Primary Diagnosis

This 25-year-old female is presenting with diabetic ketoacidosis (DKA), evidenced by the urinalysis showing >2000 mg/dL glucose and large ketones. The upper GI discomfort (nausea, vomiting, abdominal pain) is a classic presenting symptom of DKA, not a primary gastrointestinal disorder 1, 2. The large blood and protein on urinalysis require investigation but should not delay immediate DKA management.

Immediate Diagnostic Workup

Obtain the following laboratory tests immediately 3, 4:

  • Arterial or venous blood gas for pH assessment (DKA diagnosis requires pH <7.3)
  • Complete metabolic panel including electrolytes, BUN, creatinine
  • Serum ketones (β-hydroxybutyrate preferred over nitroprusside method)
  • Calculated anion gap (DKA requires >10-12 mEq/L)
  • Serum osmolality
  • Complete blood count with differential
  • Electrocardiogram with continuous cardiac monitoring
  • Blood and urine cultures if infection suspected as precipitant

The hematuria and proteinuria warrant additional evaluation once DKA is stabilized, as these may represent diabetic nephropathy, urinary tract infection, or unrelated renal pathology 1.

Immediate Management Protocol

Fluid Resuscitation

Begin with balanced electrolyte solutions or 0.9% normal saline at 15-20 mL/kg/hour (approximately 1-1.5 L in the first hour) to restore circulatory volume and tissue perfusion 3, 4. Continue fluid replacement to correct estimated deficits within 24 hours, ensuring serum osmolality changes do not exceed 3 mOsm/kg/hour 3.

Insulin Therapy

Administer continuous intravenous regular insulin at 0.1 units/kg/hour without an initial bolus 3, 4. The American Diabetes Association now recommends omitting the initial bolus in most cases 3.

Critical monitoring points 1, 3:

  • Check blood glucose every 1-2 hours
  • If glucose does not fall by 50 mg/dL in the first hour, double the insulin infusion hourly until achieving a steady decline of 50-75 mg/dL per hour
  • When glucose reaches 200-250 mg/dL, add dextrose-containing fluids (D5W or D10W) to maintain glucose 100-180 mg/dL while continuing insulin to clear ketosis 1, 3

Do not stop insulin when glucose normalizes—ketone clearance takes longer than glucose correction 1, 4.

Electrolyte Management

Potassium replacement is critical 3, 4:

  • If initial potassium <3.3 mEq/L, delay insulin until potassium is restored to prevent life-threatening arrhythmias, cardiac arrest, and respiratory muscle weakness 3, 4
  • Once potassium falls below 5.5 mEq/L (assuming adequate urine output), add 20-40 mEq/L potassium to infusion fluids 3
  • Use 2/3 KCl and 1/3 KPO4 to maintain serum potassium 4-5 mEq/L 3

Bicarbonate therapy is NOT recommended—multiple studies show no benefit in resolution of acidosis or time to discharge 1, 3, 4.

Monitoring Parameters

Draw blood every 2-4 hours for serum electrolytes, glucose, BUN, creatinine, osmolality, and venous pH 1, 3. Venous pH (typically 0.03 units lower than arterial pH) and anion gap can be followed to monitor resolution 3.

DKA Resolution Criteria

DKA is resolved when ALL of the following are achieved 3, 5:

  • Glucose <200 mg/dL
  • Serum bicarbonate ≥18 mEq/L
  • Venous pH >7.3
  • Anion gap ≤12 mEq/L

Transition to Subcutaneous Insulin

Administer basal insulin (intermediate or long-acting) 2-4 hours BEFORE stopping IV insulin to prevent recurrence of ketoacidosis and rebound hyperglycemia 1, 3, 4. This timing is critical and non-negotiable.

For newly diagnosed patients, initiate a multidose regimen of short- and intermediate/long-acting insulin at approximately 0.5-1.0 units/kg/day 3.

Identifying Precipitating Causes

Search for underlying triggers 1, 4:

  • Infection (most common precipitant)—obtain cultures and start empiric antibiotics if suspected
  • New-onset diabetes (25-30% of type 1 diabetes presents with DKA) 6
  • Insulin omission or inadequate dosing
  • Myocardial infarction or stroke
  • SGLT2 inhibitor use (can cause euglycemic DKA)—discontinue if present 3, 5

Addressing the Hematuria and Proteinuria

Once DKA is stabilized, investigate the urinary findings:

  • Repeat urinalysis after metabolic correction (some hematuria/proteinuria may be transient from severe hyperglycemia and dehydration)
  • Urine microscopy to differentiate glomerular from non-glomerular hematuria
  • Urine culture to exclude urinary tract infection
  • Consider renal ultrasound if findings persist
  • Evaluate for diabetic nephropathy with urine albumin-to-creatinine ratio once stable

Critical Pitfalls to Avoid

Do not stop IV insulin when glucose normalizes—continue until ketoacidosis resolves (pH >7.3, bicarbonate ≥18 mEq/L, anion gap ≤12 mEq/L) 1, 3.

Do not give insulin if potassium <3.3 mEq/L—this can cause fatal arrhythmias 3, 4.

Do not forget basal insulin 2-4 hours before stopping IV insulin—this prevents rebound hyperglycemia and recurrent DKA 1, 3.

Monitor for cerebral edema (rare but fatal complication)—avoid overly rapid correction of osmolality (maximum 3 mOsm/kg/hour) 1, 3.

Disposition and Prevention

Admit to intensive care unit for continuous monitoring given the severity of presentation 1.

Discharge planning must include 3, 4:

  • Identification of outpatient diabetes care provider
  • Education on DKA recognition, prevention, and sick-day management
  • Insulin administration technique verification
  • Follow-up within 1-2 weeks
  • Emphasis on never discontinuing insulin, even during illness 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diabetic Ketoacidosis: Evaluation and Treatment.

American family physician, 2024

Guideline

Management of Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Diabetic Ketoacidosis with Concurrent Hypertriglyceridemia-Induced Pancreatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosing Euglycemic Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Comprehensive review of diabetic ketoacidosis: an update.

Annals of medicine and surgery (2012), 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.